Dr. Modjarrad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health
40 Convent Drive, Room 2508 MSC3017
Bethesda, MD 20892Phone+1 301-594-8555
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2012 - 2013
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2010 - 2012
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2010
- Yale-New Haven Medical CenterInternship, Internal Medicine, 2006 - 2007
- University of Alabama School of MedicineClass of 2006
Certifications & Licensure
- MD State Medical License 2016 - 2025
- WV State Medical License 2012 - 2025
- VA State Medical License 2012 - 2016
- TN State Medical License 2010 - 2014
Publications & Presentations
PubMed
- 12 citationsSafety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.Juleen Gayed, Oyeniyi Diya, Francine S Lowry, Xia Xu, Vishva Bangad
Vaccines. 2024-01-24 - 38 citationsReport from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7-9th Sep 2015Birgitte K. Giersing, Kayvon Modjarrad, David C. Kaslow, Vasee S. Moorthy
Vaccine. 2016-06-03 - 36 citations3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Presence of Age-Related Macular Degeneration in the Cardiovascular Health StudyGerald McGwin, Kayvon Modjarrad, Tyler Andrew Hall, Aiyuan Xie, Cynthia Owsley
Archives of Ophthalmology. 2006-01-01
Press Mentions
- Development of Universal COVID Vaccine Emerges as New Challenge for Pharmaceutical IndustryApril 23rd, 2022
- Pan-Coronavirus Vaccines May Be Key to Fighting Future PandemicsMarch 8th, 2022
- U.S. Army Begins Human Trials of Pan-Coronavirus VaccineJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: